On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...